ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

October 26, 2007

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

The View Forom The White House On Research Funding

August 16, 1991

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

USC wins $3.5 million NCI grant.

April 23, 2004